Former Microsoft Israel R&D President To Raise VC fund
Former Microsoft Israel R&D president, Moshe Lichtman, and former NICE Systems CEO and the former director general of the Israeli Ministry of Finance, Haim Shani, will try to raise $100-150 million for a venture capital fund. Israeli media reported that the fund will make investments of a few million dollars into late-stage startups seeking growth. The two […]
March 07, 2012
‘BiolineRX’ Granted Approval For Phase II Bowel Disease Trial
Drug development company BiolineRX announced that it has received approval from Israel’s Ministry of Health to commence a Phase II trial of its treatment for inflammatory bowel disease (IBD). The company reported that the Phase II trial will be an open-label study to evaluate the efficacy, safety and tolerability of the treatment, BL-7040, in up […]
March 06, 2012
‘RayV’ New Cloud-Based Platform For TV Streaming
Israeli startup RayV today launched their new Optimized Cloud Streaming – an infrastructure for HDTV streaming over the Internet that allows broadcasting content across multiple IP networks. The platform is targeted to companies that deliver video broadcasts, such as cellular companies or content providers. According to Calcalist website, the company already secured investments of $40 million. […]
March 06, 2012
‘Teva’: Positive Results In Phase III Trial For Rhinitis Nasal Spray
Teva Pharmaceutical Industries reported positive results from Phase III clinical studies for its QNASL nasal spray. The spray is designed to treat seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR). The trials tested the efficacy and safety of the spray, as well as the impact on quality of life. The results were reported at […]
March 06, 2012
Mobile Ads ‘Amobee’ Sold For $321m To Singapore Telecommunications
The largest telecom services provider in the Asia Pacific region, Singapore Telecommunications (Singtel), announced that it has acquired mobile advertising solutions provider Amobee Inc. for $321 million in cash. Since its foundation in 2005, Amobee raised $54 million. The company develops software that customizes ads to users of mobile phone media, such as video clips, […]
March 05, 2012
‘BG Negev’ Raises $1M For Neurodegenerative Diseases Study
BG Negev Technologies and Applications, the technology transfer company of Ben Gurion University of the Negev, has raised $1 million from a US private equity fund, to develop therapies for neurodegenerative diseases. The funding will support a study conducted by the university’s Department of Immunology and Microbiology, which might be useful for prolonging lifespans for […]
March 05, 2012
‘Gamida Cell’ To Raise $10M For Stem Cell Therapy
Israeli company Gamida Cell will raise $10 million in an internal round from its shareholders, including an owners’ loan of $4 million. Elbit Medical Technologies, which owns 31.6% of Gamida Cell, will invest $3 million in the round. Gamida Cell develops stem cell therapy products for transplantation and regenerative medicine. It is soon to start a […]
March 05, 2012
‘Procognia’ Signs Distribution Deal In China And Taiwan
Procognia (Israel) signed a binding three-year letter of intent with Cytech – a Hong-Kong based distributor of life sciences products – for the exclusive distribution of Procognia’s blood sugar analysis kits in China and Taiwan. According to the deal, Procognia will receive a percentage of sales and revenue from the analysis services. The Glycoscope kit […]
March 05, 2012
‘Soluto’ First Non-US App On Windows 8 Store
Israeli Tech-assistance app Soluto will be the first non-US app to be released on the Windows 8 Store. Microsoft revealed its Windows 8 Beta version at the Mobile World Congress in Barcelona. The App store includes 70 applications. Soluto’s platform enables users without any formal technical background to receive remote technical support from friends and […]
March 02, 2012
‘Kardan’ Signs $98M Water Infrastructure Deal With Ghana
Kardan N.V., a water infrastructure subsidiary of Israeli Tahal Consulting Engineers, announced that it has signed an agreement with the National Water Company of Ghana for a project to design, construct and upgrade the drinking water systems in three regions of Ghana. The project’s estimated revenues are $97.5 million. It is the follow-up to an existing […]
March 01, 2012
Israel To Sell China Water Technologies For $300M
Israeli Finance Ministry announced that Israel will sell China water technology valued at $300 million for use in the agriculture sector. According to the statement the deal was signed by both countries’ finance ministers in Beijing. No information was given regarding the technologies and companies involved in the deal. The statement also noted that officials […]
February 29, 2012
FDA Approves ‘Thrombotech’ Phase IIa Trial For Stroke Treatment
Israeli biotechnology company Thrombotech has obtained US Food and Drug Administration (FDA) approval for a Phase IIa clinical trial of its treatment for ischemic stroke by destroying blood clots. The trial will be conducted in the US and will test the safety of the drug, THR-18. The clinical trial was initiated at Hadassah Medical Center […]
February 29, 2012
Israeli Technology Exports Reach $9.5 Billion In 2010
Israeli companies exported in 2010 $9.5 billion in technological services, such as R&D, and licensing agreements on patents and know-how. According to a report published by the National Council for R&D at the Ministry of Science and Technology, this is a 3.4% drop from 2009, but a 17% rise compared with 2007. The same year, […]
February 29, 2012
‘Amiad Water Systems’ Awarded $10M For Australian Projects
Israeli company Amiad Water Systems announced it has been awarded two projects in Australia, for a sum of $10 million. The larger of the projects is for Perth’s Southern SeaWater Desalination Plant, for which Amiad will provide automatic self-cleaning screen filter technology for seawater reverse osmosis membrane protection. The second is for Origin Energy, one […]
February 28, 2012
‘Otic Pharma’ Raises $4.3m For Ear Treatment Drug
Global healthcare investment firm OrbiMed Advisors invested $4.3 million in Otic Pharma, an Israeli company that develops foam-based treatments for ear diseases. “Foam-Otic”, according to the company, is considered to be a more efficient drug than ear drops, with lower and less frequent doses. Otic Pharma is about to complete a clinical trial to test the […]
February 27, 2012